Fetal Development and Genetics — Chapter 10
Stages of Fetal Development
- Preembryonic stage (fertilization through the second week): fertilization; cleavage; morula; blastocyst and trophoblast; implantation.
- Embryonic stage (end of the second week through the eighth week): basic structures of major body organs and main external features (Table 10.1).
- Fetal stage (end of the eighth week until birth): ongoing growth and maturation (Table 10.1).
Embryonic Layers
- Ectoderm: forms CNS, special senses, skin, and glands.
- Mesoderm: forms skeletal, urinary, circulatory, and reproductive systems.
- Endoderm: forms respiratory system, liver, pancreas, and digestive system.
Q: Do CNS structures arise from the mesoderm? A: False—the CNS arises from the ectoderm.
Placenta and Functions
- Interface between the pregnant person and fetus; hormone production to regulate maternal physiology; immune protection for fetus; waste removal; promotes nutrient delivery; hormones support fetal organ maturation.
- Hormones produced: , , , , .
Umbilical Cord
- Formed from the amnion; lifeline from mother to fetus.
- Contents: one vein (oxygenated) and two arteries (deoxygenated).
- Wharton jelly surrounds vessels to prevent compression.
- At term: length ≈ ; width ≈ .
Role of Amniotic Fluid
- Maintains constant fetal temperature; supports symmetric growth; cushions fetus; prevents umbilical cord compression; promotes fetal movement for musculoskeletal development.
- Conditions: oligohydramnios = low fluid; polyhydramnios = excessive fluid.
Fetal Circulation
- Blood travels placenta → fetus → placenta.
- Shunts (close after birth):
- Ductus venosus: umbilical vein → inferior vena cava
- Ductus arteriosus: main pulmonary artery → aorta
- Foramen ovale: right atrium → left atrium
Genetics and Advances
- Study of heredity and variation; pharmacogenomics; part of perinatal care; genetic testing; gene therapy.
- Human Genome Project: International 13-year effort started in 1990 to map, sequence, and determine function of all human genes; genome defines genotype and phenotype.
Karyotype and Chromosomes
- Karyotype: pictorial analysis of chromosome number, form, and size.
- Commonly uses white blood cells and fetal cells in amniotic fluid.
- Chromosomes numbered 1–22 by size; sex chromosomes X and Y.
- Examples: Down syndrome = Trisomy 21; Turner syndrome = monosomy X; Klinefelter = XXY; Fragile X = Fragile X.
Patterns of Inheritance
- Mendelian or monogenic disorders:
- Autosomal dominant
- Autosomal recessive
- X-linked (recessive and dominant)
- Multifactorial disorders.
- Nontraditional inheritance; both parents may be carriers.
Autosomal Inheritance
- Autosomal Dominant: one normal and one affected parent.
- Autosomal Recessive: 25% risk of an affected child.
X-linked Inheritance
- X-linked Recessive: typically more males affected because they have a single X chromosome; affected male pattern shown with female carriers.
- X-linked Dominant: affected individuals include both sexes; inheritance pattern varies (fathers pass to daughters).
Chromosomal Abnormalities
- Numerical: monosomies, trisomies, polyploidy.
- Structural: deletions, inversions, translocations.
- Sex chromosome abnormalities.
Types of Chromosomal Abnormalities
- Structural: Cri du Chat syndrome; Fragile X syndrome.
- Sex chromosome: Turner syndrome (monosomy X); Klinefelter syndrome (XXY).
Genetic Evaluation and Counseling
- Genetic counseling: process of advising at-risk individuals about disorder, probability, and management/family planning options.
- Ideal timing: before conception; various indications Box 10.2.
Nursing Roles and Responsibilities
- Begin preconception counseling; collect family history; refer for genetic testing; explain screening/diagnostic test purposes, risks, and benefits.
- Address costs, insurance, and potential discrimination; protect privacy; support emotional responses; provide referrals to support groups.
Ethical, Legal, and Social Considerations
- Potential misuse of genetic information: risk profiling; privacy breaches; workplace discrimination; loss of autonomy; issues with pre-symptomatic risk assessment.